Related Articles
Anti‑PD‑1 immune checkpoint inhibitor inducing endocrine toxicity in a patient with advanced lung cancer: A case report and literature review
Isolated adrenocorticotropic hormone deficiency potentially induced by nivolumab following pseudo‑progression in clear cell renal cell carcinoma: A case report
Safety and tolerability of PD-1/PD-L1 inhibitors in elderly and frail patients with advanced malignancies
Clinical features of immune‑related thyroid dysfunction and its association with outcomes in patients with advanced malignancies treated by PD‑1 blockade
Proton beam therapy combined with retrograde intra‑arterial infusion chemotherapy for an extremely rapid growing recurrent ameloblastic carcinoma: A case report